GLP-1 S 5mg
GLP-based research peptide studied for incretin receptor signaling, glucose-regulation pathways, and metabolic system models.
Compound Overview
GLP-1 S is a glucagon-like peptide–based analogue evaluated in laboratory environments for its interaction with GLP-1 receptors and related incretin signaling pathways. GLP-1 receptor activation is associated with glucose-dependent metabolic signaling and endocrine regulatory processes.
In experimental research models, GLP-1 analogues are commonly studied for their involvement in metabolic regulation systems, pancreatic beta-cell signaling pathways, and appetite-related hormonal responses. Research frequently investigates receptor binding activity, intracellular signaling cascades, and coordinated endocrine feedback mechanisms.
Receptor Activity
Targets GLP-1 receptors involved in incretin signaling, glucose-regulation pathways, and metabolic system research.
Metabolic Research Focus
Commonly studied in laboratory models examining insulin signaling, appetite regulation pathways, and endocrine metabolic interactions.
Laboratory Classification
Classified as a GLP-based research peptide analogue for experimental and analytical research applications.
Product Specifications
- Product Name: GLP-1 S
- Peptide Type: GLP-1 analogue
- Quantity: 5mg per vial
- Form: Lyophilized peptide powder
- Intended Use: Research use only







Reviews
There are no reviews yet.